nodes	percent_of_prediction	percent_of_DWPC	metapath
Decamethonium—ACHE—Irinotecan—hematologic cancer	0.188	0.346	CbGbCtD
Decamethonium—BCHE—Triamcinolone—hematologic cancer	0.15	0.275	CbGbCtD
Decamethonium—BCHE—Irinotecan—hematologic cancer	0.113	0.209	CbGbCtD
Decamethonium—BCHE—Cisplatin—hematologic cancer	0.0925	0.17	CbGbCtD
Decamethonium—CHRNE—blood—hematologic cancer	0.0255	0.144	CbGeAlD
Decamethonium—CHRNE—testis—hematologic cancer	0.0211	0.119	CbGeAlD
Decamethonium—HRH3—hematopoietic system—hematologic cancer	0.0158	0.0887	CbGeAlD
Decamethonium—CHRNG—blood—hematologic cancer	0.0128	0.0718	CbGeAlD
Decamethonium—CHRNA1—hematopoietic system—hematologic cancer	0.0128	0.0717	CbGeAlD
Decamethonium—CHRNG—bone marrow—hematologic cancer	0.0124	0.0695	CbGeAlD
Decamethonium—CHRNG—lung—hematologic cancer	0.0112	0.0629	CbGeAlD
Decamethonium—HRH3—blood—hematologic cancer	0.0105	0.0588	CbGeAlD
Decamethonium—CHRND—lung—hematologic cancer	0.00888	0.0499	CbGeAlD
Decamethonium—CHRNA2—blood—hematologic cancer	0.00701	0.0394	CbGeAlD
Decamethonium—CHRNB1—blood—hematologic cancer	0.00653	0.0367	CbGeAlD
Decamethonium—CHRNB1—testis—hematologic cancer	0.0054	0.0303	CbGeAlD
Decamethonium—ACHE—testis—hematologic cancer	0.00468	0.0263	CbGeAlD
Decamethonium—BCHE—hematopoietic system—hematologic cancer	0.0042	0.0236	CbGeAlD
Decamethonium—CHRNB1—lymph node—hematologic cancer	0.00391	0.022	CbGeAlD
Decamethonium—ACHE—lymph node—hematologic cancer	0.00339	0.0191	CbGeAlD
Decamethonium—BCHE—blood—hematologic cancer	0.00278	0.0156	CbGeAlD
Decamethonium—BCHE—bone marrow—hematologic cancer	0.00269	0.0151	CbGeAlD
Decamethonium—BCHE—lung—hematologic cancer	0.00244	0.0137	CbGeAlD
Decamethonium—BCHE—testis—hematologic cancer	0.0023	0.0129	CbGeAlD
Decamethonium—BCHE—lymph node—hematologic cancer	0.00167	0.00937	CbGeAlD
Decamethonium—Sodium lauryl sulfate—ALB—hematologic cancer	0.00131	1	CrCbGaD
Decamethonium—CHRM2—GPCR downstream signaling—RASGRP1—hematologic cancer	4.8e-05	0.000173	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—CD80—hematologic cancer	4.79e-05	0.000173	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—PIK3CG—hematologic cancer	4.78e-05	0.000172	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—KIT—hematologic cancer	4.78e-05	0.000172	CbGpPWpGaD
Decamethonium—HRH3—Signaling by GPCR—NRAS—hematologic cancer	4.78e-05	0.000172	CbGpPWpGaD
Decamethonium—CHRM2—GPCR ligand binding—CCL2—hematologic cancer	4.77e-05	0.000172	CbGpPWpGaD
Decamethonium—BCHE—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	4.75e-05	0.000172	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—JAK3—hematologic cancer	4.75e-05	0.000172	CbGpPWpGaD
Decamethonium—ACHE—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	4.7e-05	0.00017	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—PTPN11—hematologic cancer	4.69e-05	0.000169	CbGpPWpGaD
Decamethonium—ACHE—Neuronal System—HRAS—hematologic cancer	4.69e-05	0.000169	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—CXCR4—hematologic cancer	4.67e-05	0.000169	CbGpPWpGaD
Decamethonium—HRH3—Signaling by GPCR—MAPK3—hematologic cancer	4.57e-05	0.000165	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—CCR7—hematologic cancer	4.55e-05	0.000164	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—CXCL13—hematologic cancer	4.55e-05	0.000164	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—CREB1—hematologic cancer	4.55e-05	0.000164	CbGpPWpGaD
Decamethonium—BCHE—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	4.55e-05	0.000164	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—CYCS—hematologic cancer	4.54e-05	0.000164	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—HSP90AA1—hematologic cancer	4.52e-05	0.000163	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—IL3—hematologic cancer	4.5e-05	0.000163	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—NCOR2—hematologic cancer	4.49e-05	0.000162	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—BRAF—hematologic cancer	4.49e-05	0.000162	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—CCL2—hematologic cancer	4.45e-05	0.000161	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—IL3RA—hematologic cancer	4.44e-05	0.00016	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—CRKL—hematologic cancer	4.44e-05	0.00016	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—IL6R—hematologic cancer	4.44e-05	0.00016	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—CREBBP—hematologic cancer	4.43e-05	0.00016	CbGpPWpGaD
Decamethonium—BCHE—Metabolism of proteins—CCL2—hematologic cancer	4.41e-05	0.000159	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—RASGRP1—hematologic cancer	4.36e-05	0.000157	CbGpPWpGaD
Decamethonium—CHRM2—GPCR downstream signaling—GRB2—hematologic cancer	4.31e-05	0.000156	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—NQO1—hematologic cancer	4.28e-05	0.000155	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—CD44—hematologic cancer	4.28e-05	0.000155	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—RGS2—hematologic cancer	4.28e-05	0.000155	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—CMA1—hematologic cancer	4.23e-05	0.000153	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—TRIO—hematologic cancer	4.23e-05	0.000153	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—TRH—hematologic cancer	4.23e-05	0.000153	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—MAP2K1—hematologic cancer	4.23e-05	0.000153	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—PIK3CD—hematologic cancer	4.2e-05	0.000152	CbGpPWpGaD
Decamethonium—BCHE—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	4.2e-05	0.000151	CbGpPWpGaD
Decamethonium—BCHE—Neuronal System—HRAS—hematologic cancer	4.18e-05	0.000151	CbGpPWpGaD
Decamethonium—HRH3—GPCR downstream signaling—PIK3CA—hematologic cancer	4.16e-05	0.00015	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—AGO2—hematologic cancer	4.14e-05	0.00015	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—SPHK1—hematologic cancer	4.14e-05	0.00015	CbGpPWpGaD
Decamethonium—HRH3—Signaling by GPCR—KRAS—hematologic cancer	4.11e-05	0.000148	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—HDAC9—hematologic cancer	4.1e-05	0.000148	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—LPAR1—hematologic cancer	4.1e-05	0.000148	CbGpPWpGaD
Decamethonium—ACHE—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	4.06e-05	0.000147	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—H3F3B—hematologic cancer	4.06e-05	0.000147	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—CYCS—hematologic cancer	4.05e-05	0.000146	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—HSP90AA1—hematologic cancer	4.03e-05	0.000145	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—FGF2—hematologic cancer	4.02e-05	0.000145	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—GSTP1—hematologic cancer	4.01e-05	0.000145	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—PIK3R1—hematologic cancer	3.97e-05	0.000143	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—GRB2—hematologic cancer	3.92e-05	0.000141	CbGpPWpGaD
Decamethonium—ACHE—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	3.88e-05	0.00014	CbGpPWpGaD
Decamethonium—CHRM2—GPCR downstream signaling—CSF2—hematologic cancer	3.85e-05	0.000139	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—JAK2—hematologic cancer	3.85e-05	0.000139	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—ABCB1—hematologic cancer	3.79e-05	0.000137	CbGpPWpGaD
Decamethonium—HRH3—Signaling by GPCR—PIK3CA—hematologic cancer	3.78e-05	0.000136	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—PDE4B—hematologic cancer	3.77e-05	0.000136	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—CNR2—hematologic cancer	3.77e-05	0.000136	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—MDM2—hematologic cancer	3.76e-05	0.000136	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—FGF19—hematologic cancer	3.74e-05	0.000135	CbGpPWpGaD
Decamethonium—CHRM2—GPCR downstream signaling—JAK1—hematologic cancer	3.72e-05	0.000134	CbGpPWpGaD
Decamethonium—CHRM2—GPCR downstream signaling—PRKCG—hematologic cancer	3.72e-05	0.000134	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—RAC2—hematologic cancer	3.71e-05	0.000134	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—DKK1—hematologic cancer	3.68e-05	0.000133	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—GSTM1—hematologic cancer	3.68e-05	0.000133	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—NCOR1—hematologic cancer	3.68e-05	0.000133	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—PIK3CB—hematologic cancer	3.66e-05	0.000132	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—MTOR—hematologic cancer	3.66e-05	0.000132	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—STAT5B—hematologic cancer	3.65e-05	0.000132	CbGpPWpGaD
Decamethonium—BCHE—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	3.63e-05	0.000131	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—GSTP1—hematologic cancer	3.57e-05	0.000129	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—ADCY7—hematologic cancer	3.55e-05	0.000128	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—CSF2—hematologic cancer	3.5e-05	0.000126	CbGpPWpGaD
Decamethonium—HRH3—Signaling by GPCR—HRAS—hematologic cancer	3.49e-05	0.000126	CbGpPWpGaD
Decamethonium—CHRM2—GPCR downstream signaling—IL2RA—hematologic cancer	3.47e-05	0.000125	CbGpPWpGaD
Decamethonium—BCHE—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	3.46e-05	0.000125	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—XIAP—hematologic cancer	3.45e-05	0.000125	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—CDKN1B—hematologic cancer	3.43e-05	0.000124	CbGpPWpGaD
Decamethonium—HRH3—GPCR downstream signaling—AKT1—hematologic cancer	3.4e-05	0.000123	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—ABCB1—hematologic cancer	3.38e-05	0.000122	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—JAK1—hematologic cancer	3.38e-05	0.000122	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—PRKCG—hematologic cancer	3.38e-05	0.000122	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—CASP3—hematologic cancer	3.37e-05	0.000122	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—SH2B3—hematologic cancer	3.36e-05	0.000121	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—SMARCA4—hematologic cancer	3.36e-05	0.000121	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—IL2—hematologic cancer	3.36e-05	0.000121	CbGpPWpGaD
Decamethonium—HRH3—Signaling by GPCR—IL6—hematologic cancer	3.34e-05	0.000121	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—GZMB—hematologic cancer	3.34e-05	0.000121	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—NCOR1—hematologic cancer	3.28e-05	0.000119	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—GSTM1—hematologic cancer	3.28e-05	0.000119	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—CCND1—hematologic cancer	3.28e-05	0.000118	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—JUN—hematologic cancer	3.27e-05	0.000118	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—CTNNA1—hematologic cancer	3.26e-05	0.000118	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—MTHFR—hematologic cancer	3.25e-05	0.000117	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—HSPB1—hematologic cancer	3.24e-05	0.000117	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—EIF4EBP1—hematologic cancer	3.24e-05	0.000117	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—CCL3—hematologic cancer	3.24e-05	0.000117	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—PTHLH—hematologic cancer	3.21e-05	0.000116	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—SDC1—hematologic cancer	3.21e-05	0.000116	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—CDKN1A—hematologic cancer	3.17e-05	0.000114	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—PTEN—hematologic cancer	3.16e-05	0.000114	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—IL2RA—hematologic cancer	3.15e-05	0.000114	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—PTGER4—hematologic cancer	3.12e-05	0.000113	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—LCK—hematologic cancer	3.11e-05	0.000112	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—MAPK8—hematologic cancer	3.09e-05	0.000112	CbGpPWpGaD
Decamethonium—HRH3—Signaling by GPCR—AKT1—hematologic cancer	3.09e-05	0.000111	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—H3F3A—hematologic cancer	3.05e-05	0.00011	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—EP300—hematologic cancer	3.02e-05	0.000109	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—PRKCZ—hematologic cancer	2.96e-05	0.000107	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—SRC—hematologic cancer	2.93e-05	0.000106	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—MTHFR—hematologic cancer	2.9e-05	0.000105	CbGpPWpGaD
Decamethonium—CHRM2—GPCR downstream signaling—PIK3CG—hematologic cancer	2.89e-05	0.000105	CbGpPWpGaD
Decamethonium—ACHE—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.87e-05	0.000104	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—PARP1—hematologic cancer	2.86e-05	0.000103	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—VEGFA—hematologic cancer	2.86e-05	0.000103	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—STAT3—hematologic cancer	2.83e-05	0.000102	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—NRAS—hematologic cancer	2.82e-05	0.000102	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—FBXW7—hematologic cancer	2.81e-05	0.000102	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—HDAC2—hematologic cancer	2.76e-05	9.96e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—CXCR4—hematologic cancer	2.76e-05	9.96e-05	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—PIK3CG—hematologic cancer	2.73e-05	9.87e-05	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—MAPK3—hematologic cancer	2.7e-05	9.76e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—CBL—hematologic cancer	2.69e-05	9.71e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—IL3—hematologic cancer	2.66e-05	9.61e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—PIK3CG—hematologic cancer	2.63e-05	9.49e-05	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—MYC—hematologic cancer	2.63e-05	9.49e-05	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—TGFB1—hematologic cancer	2.62e-05	9.47e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—PTPN1—hematologic cancer	2.62e-05	9.44e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—PTPN11—hematologic cancer	2.58e-05	9.32e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—RASGRP1—hematologic cancer	2.57e-05	9.29e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—SYK—hematologic cancer	2.56e-05	9.26e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—HSP90AA1—hematologic cancer	2.56e-05	9.26e-05	CbGpPWpGaD
Decamethonium—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.56e-05	9.23e-05	CbGpPWpGaD
Decamethonium—CHRM2—GPCR downstream signaling—PIK3CD—hematologic cancer	2.54e-05	9.19e-05	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—CREBBP—hematologic cancer	2.53e-05	9.15e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—CREB1—hematologic cancer	2.5e-05	9.03e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—STAT1—hematologic cancer	2.47e-05	8.93e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—CCL2—hematologic cancer	2.45e-05	8.84e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—IL6R—hematologic cancer	2.44e-05	8.81e-05	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—PIK3CG—hematologic cancer	2.44e-05	8.8e-05	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—KRAS—hematologic cancer	2.43e-05	8.77e-05	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—PIK3CD—hematologic cancer	2.4e-05	8.68e-05	CbGpPWpGaD
Decamethonium—CHRM2—GPCR downstream signaling—PIK3R1—hematologic cancer	2.4e-05	8.68e-05	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—ALB—hematologic cancer	2.37e-05	8.56e-05	CbGpPWpGaD
Decamethonium—CHRM2—GPCR downstream signaling—JAK2—hematologic cancer	2.34e-05	8.43e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—MAP2K1—hematologic cancer	2.33e-05	8.4e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—GRB2—hematologic cancer	2.31e-05	8.36e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—PIK3CD—hematologic cancer	2.31e-05	8.34e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—PDGFA—hematologic cancer	2.31e-05	8.33e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—KITLG—hematologic cancer	2.28e-05	8.22e-05	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—PIK3R1—hematologic cancer	2.27e-05	8.19e-05	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—CREBBP—hematologic cancer	2.26e-05	8.16e-05	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—PIK3CA—hematologic cancer	2.23e-05	8.06e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—STAT5A—hematologic cancer	2.22e-05	8.03e-05	CbGpPWpGaD
Decamethonium—CHRM2—GPCR downstream signaling—PIK3CB—hematologic cancer	2.22e-05	8.01e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—CDKN2B—hematologic cancer	2.2e-05	7.96e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—PIK3R1—hematologic cancer	2.18e-05	7.88e-05	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—TP53—hematologic cancer	2.16e-05	7.79e-05	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—PIK3CD—hematologic cancer	2.14e-05	7.74e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—CD86—hematologic cancer	2.13e-05	7.7e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—JAK2—hematologic cancer	2.12e-05	7.66e-05	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—ALB—hematologic cancer	2.12e-05	7.64e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—HES1—hematologic cancer	2.1e-05	7.59e-05	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—PIK3CB—hematologic cancer	2.09e-05	7.56e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—NCOR1—hematologic cancer	2.09e-05	7.55e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—CSF2—hematologic cancer	2.07e-05	7.47e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—FGF1—hematologic cancer	2.07e-05	7.47e-05	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—HRAS—hematologic cancer	2.06e-05	7.45e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—FOXO1—hematologic cancer	2.04e-05	7.36e-05	CbGpPWpGaD
Decamethonium—CHRM2—GPCR downstream signaling—IL2—hematologic cancer	2.04e-05	7.35e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—PDGFRB—hematologic cancer	2.03e-05	7.34e-05	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—PIK3R1—hematologic cancer	2.02e-05	7.31e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—PIK3CB—hematologic cancer	2.01e-05	7.27e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—PDGFRA—hematologic cancer	2e-05	7.23e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—PRKCG—hematologic cancer	2e-05	7.21e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—JAK1—hematologic cancer	2e-05	7.21e-05	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—IL6—hematologic cancer	1.98e-05	7.13e-05	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—PIK3CB—hematologic cancer	1.87e-05	6.75e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—IL2RA—hematologic cancer	1.86e-05	6.73e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—IL2—hematologic cancer	1.85e-05	6.68e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—TERT—hematologic cancer	1.84e-05	6.65e-05	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—AKT1—hematologic cancer	1.82e-05	6.58e-05	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—PTEN—hematologic cancer	1.81e-05	6.53e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—PDGFB—hematologic cancer	1.8e-05	6.49e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—TSC2—hematologic cancer	1.76e-05	6.35e-05	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—EP300—hematologic cancer	1.73e-05	6.23e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—FGFR3—hematologic cancer	1.69e-05	6.11e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—MAPK14—hematologic cancer	1.67e-05	6.05e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—ESR1—hematologic cancer	1.64e-05	5.93e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—FN1—hematologic cancer	1.62e-05	5.86e-05	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—PTEN—hematologic cancer	1.61e-05	5.83e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—BAD—hematologic cancer	1.6e-05	5.79e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—NFKBIA—hematologic cancer	1.6e-05	5.79e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—NOTCH1—hematologic cancer	1.59e-05	5.73e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—CD80—hematologic cancer	1.56e-05	5.62e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—KIT—hematologic cancer	1.55e-05	5.61e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—PIK3CG—hematologic cancer	1.55e-05	5.61e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—NRAS—hematologic cancer	1.55e-05	5.61e-05	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—EP300—hematologic cancer	1.54e-05	5.56e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—PTPN11—hematologic cancer	1.53e-05	5.51e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—MAPK3—hematologic cancer	1.49e-05	5.37e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—CREB1—hematologic cancer	1.48e-05	5.34e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—BRAF—hematologic cancer	1.46e-05	5.27e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—CCL2—hematologic cancer	1.45e-05	5.22e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—IL6R—hematologic cancer	1.44e-05	5.21e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—CREBBP—hematologic cancer	1.44e-05	5.2e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—MAP2K1—hematologic cancer	1.37e-05	4.96e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—PIK3CD—hematologic cancer	1.36e-05	4.93e-05	CbGpPWpGaD
Decamethonium—CHRM2—GPCR downstream signaling—PIK3CA—hematologic cancer	1.35e-05	4.88e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—KRAS—hematologic cancer	1.34e-05	4.83e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—FGF2—hematologic cancer	1.31e-05	4.72e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—PIK3R1—hematologic cancer	1.29e-05	4.65e-05	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—PIK3CA—hematologic cancer	1.28e-05	4.61e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—JAK2—hematologic cancer	1.25e-05	4.52e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—PIK3CA—hematologic cancer	1.23e-05	4.43e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—MDM2—hematologic cancer	1.22e-05	4.42e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—MTOR—hematologic cancer	1.19e-05	4.3e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—PIK3CB—hematologic cancer	1.19e-05	4.3e-05	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—PIK3CA—hematologic cancer	1.14e-05	4.11e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—HRAS—hematologic cancer	1.14e-05	4.1e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—CDKN1B—hematologic cancer	1.12e-05	4.03e-05	CbGpPWpGaD
Decamethonium—CHRM2—GPCR downstream signaling—AKT1—hematologic cancer	1.1e-05	3.99e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—CASP3—hematologic cancer	1.09e-05	3.95e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—IL2—hematologic cancer	1.09e-05	3.95e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—IL6—hematologic cancer	1.09e-05	3.93e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—CCND1—hematologic cancer	1.07e-05	3.85e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—JUN—hematologic cancer	1.06e-05	3.84e-05	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—AKT1—hematologic cancer	1.04e-05	3.77e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—CDKN1A—hematologic cancer	1.03e-05	3.72e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—PTEN—hematologic cancer	1.03e-05	3.71e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—MAPK8—hematologic cancer	1.01e-05	3.63e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—AKT1—hematologic cancer	1e-05	3.62e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—EP300—hematologic cancer	9.8e-06	3.54e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—SRC—hematologic cancer	9.53e-06	3.44e-05	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—AKT1—hematologic cancer	9.3e-06	3.36e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—VEGFA—hematologic cancer	9.29e-06	3.35e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—STAT3—hematologic cancer	9.19e-06	3.32e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—NRAS—hematologic cancer	9.17e-06	3.31e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—MAPK3—hematologic cancer	8.78e-06	3.17e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—MYC—hematologic cancer	8.54e-06	3.08e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—TGFB1—hematologic cancer	8.52e-06	3.08e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—KRAS—hematologic cancer	7.89e-06	2.85e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—PIK3CA—hematologic cancer	7.25e-06	2.62e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—TP53—hematologic cancer	7.02e-06	2.53e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—HRAS—hematologic cancer	6.71e-06	2.42e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—IL6—hematologic cancer	6.42e-06	2.32e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—AKT1—hematologic cancer	5.92e-06	2.14e-05	CbGpPWpGaD
